Blue Horseshoe Stocks: Potential Bottom-Plays & More

 Bottom-Watch Plays

We want to start things off this morning by highlighting a couple of stocks on the higher exchanges that are both currently trading at a low multiple. Stocks that trade on the NASDAQ and NYSE at less than a dollar per share for at least a month can face de-listing procedures, so companies in danger of this tend to go to great lengths to buoy their stock price.

We’re always on the lookout for possible bottom plays so we’re going to be tracking both of the following in coming sessions.

Cobalt International Energy, Inc. CIE – The de-listing alarm bells haven’t quite gone off yet at with CIE, as the PPS just fell below a buck toward the end of last month. The stock also has a recent track record of brief periods of sub-1.00 trading from which it has promptly recovered each time.

This leads us to believe that the company may not even get to the point of receiving a notice from the NYSE before share price sees a recovery. We’re going to want to be on the lookout for that potential rebound.

______

Alliqua Biomedical, Inc. ALQA – In the case of ALQA, a NASDAQ play, the situation is a bit more pressing. Shares fell below the dollar mark at the beginning of September, and the company did receive its ‘failure to satisfy listing requirement’ notice back in October. The PPS has lagged ever since, and has only until the end of April to re-attain the dollar mark, or face delisting.

We’ll be interested to follow along to see what efforts are untaken to once again satisfy listing requirements. In the meantime, the stock has found a reasonably solid base of support off of recent lows, so we’ll be on the lookout for possible rebounds.


Viacom, Inc. VIAB – Options Idea

Our regular readers know full well that we love a good earnings-related options idea, and that’s what we’ve got this morning with Viacom. The company just posted an impressive earnings beat, along with strategic guidance updates that has the stock rocking in the premarket.

We’re going to be keeping our eyes open upon the opening bell, and tracking the activity in the VIAB Weekly $44-45.50 Calls.


Extended Watchlist:
MMEG, SDVI, ISBG, ETRM, CLF, TSLA,

Blue Horseshoe Stocks: MYOS Recap, Gold Plays & More

  MYOS RENS Technology, Inc. MYOS

Easily the most solid performer that was discussed in yesterday morning’s premarket report, MYOS stole the show with everything we look for in a daily runner- an early burst that gives traders a chance at some nice intraday gains, high volume, and maintaining a good portion of the gains it makes into the close.

MYOS checked all three of those boxes yesterday, running early from its daily low of 3.61 up to a high of 5.48, which worked out to a nice 52% pop. MYOS closed at 4.72, maintaining over half of its daily advance, and did so on well over eight times the monthly average trading volume.

An all around performance like that certainly earns MYOS a continued slot on our radar screens in sessions ahead.


VanEck Vectors Gold Miners ETF (GDX)

With gold being so solid in the month of February, and indeed for most of 2017 so far, we want to rehash the idea we put forth on some GDX options and update our readers on their performance.

We initially signaled the GDX 02/10 $24-25.50 Calls in our report from January 23rd. Now set to expire on Friday, we wanted to circle back and remind our members of the kind of gains that could have been secured with this idea.

Here’s what they’ve done so far, and with gold continuing its climb, we can’t rule out seeing these upward trading range extended even further between now and the end of the week:

$24 Calls – Range: .32-1.46 – Max Gain: 356%
$24.50 Calls – Range: .19-1.05 – Max Gain: 453%
$25 Calls – Range: .11-.67 – Max Gain: 509%
$25.50 Calls – Range: .06-.39 – Max Gain: 550%

_________

Direxion Daily Gold Miners Bull 3X ETF (NUGT) - Another gold analog we’ve got a history with is NUGT, so we’re also going to highlight some contracts that have some potential here as well. Being a triple-leveraged fund, the activity in NUGT resembles that of GDX, but the magnitude of the percentage gains it has made on its chart over the same period are notably higher.

Should the massive gold rally maintain its trend, we could be looking at some serious moves in the NUGT Weekly $13-14 Calls, so that’s where we’ll set our sights with this one.


Extended Watchlist:
BTSC, NWPN, SOUM, SDVI, FNHI, CTSH

Blue Horseshoe Stocks: Fresh Bottom-Bouncers & More

Potential Bottom-Bouncers

We’re noticing a couple different possible bottom-plays that we want to start the week off by highlighting this morning:

Rite-Aid Corp. RAD – This stock has been repeat target for us at various times in the past, and we want to circle back around to it today as we’re noticing the recent activity. The stock plunged to new lows on Friday, yet regained almost all of that ground before closing nearly flat.

From the current place on the chart, and given the present indicators suggesting that a rebound could soon be forthcoming, we’re going to want to radar RAD on both the stock side of things, as well as signaling an idea in the options chain. In that case, we’re going to be interested in the RAD 02/25 $6-7 Calls, which gives us plenty of time for the stock to realize the recovery that we’re after.

______

Cymabay Therapeutics, Inc. CBAY -  CBAY is another play we’ve caught this morning as began showing signs of life after having hit its lowest PPS levels in over two months on Friday, as well as gapping up moderately in the premarket today (High: 2.15)

We’ll be looking for the stock to maintain support in the channel between the 50DMA (1.89) and 200DMA’s (1.96) on any pullbacks as things get going today. As you can see on the chart snapshot below, various indicators leading into today’s session appear favorable for CBAY.


Chatroom Call

One of the regular participants in our daily traders chats via Skype hit it big with an excellent call that was shared with the room last week. He swooped in with a sell suggestion on Friday that was perfectly timed.

Our members had a chance to jump into Nouveau Life Pharmaceuticals, Inc. NOUV at .0008 on Thursday, and the stock hit .0089 on Friday just after the following message was communicated, marking a two-day swing of 1102% The stock subsequently tanked, outlining the accuracy of DJ’s call.

As we always remind our readers, anyone is welcome to participate in our daily traders chats. Simply send a Skype contact request to username: ‘stocksumo’ and we’ll fill you in on how to join in!


Players Network, Inc. PNTV

We initially began tracking PNTV this fall, mentioning it on Oct. 20th and Nov. 8th, subsequent to which time we would witness the stock trading at a low of .0089.

We added a reminder in our report on Thursday as it had begun to ramp up heavily, and on Friday it went on to hit a new 52-week high of .048. It extends the overall gain we’ve observed in this play over the past couple of months to an impressive 439%


Extended Watchlist:
TQLA, SDVI, IFAN, PXYN(Bottom-Bouncer)

Blue Horseshoe Stocks: LEXG Run Continues & More

Lithium Exploration Group, Inc. LEXG

LEXG came out a winner once again yesterday, even as we were mentioning how many quality opportunities the stock has brought us in the past, in our morning report.

On big time volume in the neighborhood of 7.5X the monthly average. LEXG broke out to new highs, trading in an impressive daily range from .0044 to .0112, for a 155% rip.

That’s small potatoes, however, compared to the overall move we’ve witnessed since our alert during the week between Christmas and the New Year. At that time the stock saw a low of .0013, which means we’ve seen a monstrous run of 862% out of LEXG in just over three weeks’ time!


Opko Health, Inc. OPK

We’re looking at OPK as a potential bottom-play today from a technical perspective, after noticing several attractive features on the chart.

As you can see from the included snapshot, the chart is currently boasting an enormous gap to the upside, with a recent track record of making volatile swings and gap-fills. Not to mention an oversold indication from the RSI and a rapidly ripening MACD.

Additionally, we’ve got a Form-4 alert for OPK; the CEO picked up a sizable tranche of shares near yesterday’s lows (>>View Filing)

We’re going to want to keep this one on our radar for a possible rebound in the days and weeks ahead.


Extended Watchlist
HWAL, SDVI,  SOUM, SING, RMHB, IDXG

Blue Horseshoe Stocks: HIRU, OWCP Recaps & More

Hiru Corp. HIRU

Yesterday we re-signaled HIRU, a stock we’ve mentioned a couple times in 2017 already, beginning with our very first report of the year, subsequent to which we would observe a low of .0011.

So far this week, the stock has really picked up the pace with two consecutive bullish sessions. Yesterday alone it traded in a range from .0021 to a new high of .0036 just prior to the close, putting in a 71% intraday move. From our observed low, it marks an overall upswing of 227%, not to mention the fact that it closed just a single tick below that high of day at .0035.

Such a performance definitely warrants continued observation on HIRU in sessions to come.


OWC Pharmaceutical Research Corp. OWCP

Speaking of late-day pushes, we got one out of OWCP yesterday, which ran from a morning low of .21 up to .2957. That is the highest we’ve seen it yet since our next most recent report on the stock which came in mid-November.  Following that, we would catch OWCP trading as low as .085. That means, at yesterday’s new top mark, we had witnessed an overall upswing of 248% in less than two months.

If we jump back slightly further to our report dated 09/29, you can see that we actually caught this one at the subpenny level (.0045) from which yesterday’s new high represented an earth-shattering 6471% (<–That is not a typo!)

Granted the fact that yesterday’s high was its highest recorded PPS since 2014, we’d have to designate this one as a blue sky breakout, and continue to stay on its trail. Like any rapid riser, awareness of a possible dip-and-rip at some point must be maintained as well.



Biocept, Inc. BIOC

We’re also going to want to keep tabs on BIOC after yesterday monumental move on the strength of an agreement the company struck with Blue Cross & Blue Shield of Texas (>>Read PR). It’s a potentially lucrative development, and that is really showing through with the resulting activity on the chart.

With the stock having shattered previous resistance yesterday, we’re going to be monitoring for a continuation of the terrific momentum buildup from yesterday, as well as the possibility for a subsequent dip-and-rip pattern that could provide us with healthy opportunities over the course of the next few days.


Extended Watchlist:
SDVI, CRTC, PMEA, OTTV, AEPP, LXRP